Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

States Pause Lawsuits Against Insys During Bankruptcy Proceedings

Less than a month after filing for bankruptcy, Insys Therapeutics gained a reprieve from some lawsuits as well as a path forward for regulatory approval of an opioid overdose treatment.

Read More »

Amarin Plans to Double Size of Sales Force to 800

Amarin Corp. provided an update, noting that the company is increasing revenue guidance for 2019 and is planning to expand the sales force for Vascepa due to faster-than-expected growth.

Read More »

Facebook to tackle content with misleading health claims

Facebook Inc. is taking steps to reduce promotion of products based on misleading health-related claims.

Read More »

Century Therapeutics Launches with $250 Million for Induced Pluripotent Stem Cell Platform

Century Therapeutics, a startup founded by Versant Ventures, launched with $250 million in hand and a focus on developing induced pluripotent stem cell-based therapies for the treatment of hematologic and solid malignancies.

Read More »

Pfizer names former FDA chief Scott Gottlieb to board of directors

Pfizer Inc. named former U.S. Food and Drug Administration Commissioner Scott Gottlieb to the company’s board of directors.

Read More »

ImmunoGen Culls 220 Employees

ImmunoGen shares fell after the company announced the slashing of 220 employees as part of an effort to reduce ongoing expenses while recovering from an FDA rejection of an ovarian cancer drug.

Read More »

EVERSANA names life sciences digital leader Bhaskar Sambasivan to lead Patient Services

EVERSANA announced the appointment of Bhaskar Sambasivan to President, Patient Services and Chief Strategy Officer.

Read More »

San Francisco bans e-cigarette sales

San Francisco is the first major city in the United States to ban the sale of e-cigarettes as officials look to control the rapid uptick in teenage use of nicotine devices made by companies such as Juul Labs Inc.

Read More »

AbbVie Makes ‘Transformational’ Move with $63 Billion Acquisition of Allergan

Illinois-based AbbVie announced that the company will acquire Ireland-based Allergan for $63 billion in a cash and stock deal.

Read More »

Akorn gets another FDA warning letter, shares slide

Akorn Inc. received a warning letter from the U.S. Food and Drug Administration regarding a manufacturing facility in New Jersey, the latest in a string of setbacks for the generic drugmaker, sending the company’s shares down nearly 13 percent.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!


Ad Right Bottom